189 related articles for article (PubMed ID: 11851006)
1. Diabetic polyneuropathy. Axonal or demyelinating?
Valls-Canals J; Povedano M; Montero J; Pradas J
Electromyogr Clin Neurophysiol; 2002; 42(1):3-6. PubMed ID: 11851006
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological patterns of diabetic polyneuropathy.
Bagai K; Wilson JR; Khanna M; Song Y; Wang L; Fisher MA
Electromyogr Clin Neurophysiol; 2008; 48(3-4):139-45. PubMed ID: 18551834
[TBL] [Abstract][Full Text] [Related]
3. Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies.
Tankisi H; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
Clin Neurophysiol; 2007 Nov; 118(11):2383-92. PubMed ID: 17900975
[TBL] [Abstract][Full Text] [Related]
4. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies.
Trojaborg W; Hays AP; van den Berg L; Younger DS; Latov N
Muscle Nerve; 1995 Jul; 18(7):730-5. PubMed ID: 7540258
[TBL] [Abstract][Full Text] [Related]
5. Conduction slowing in diabetic distal polyneuropathy.
Herrmann DN; Ferguson ML; Logigian EL
Muscle Nerve; 2002 Aug; 26(2):232-7. PubMed ID: 12210388
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between axonal and demyelinating neuropathies: identical segments recorded from proximal and distal muscles.
Raynor EM; Ross MH; Shefner JM; Preston DC
Muscle Nerve; 1995 Apr; 18(4):402-8. PubMed ID: 7715625
[TBL] [Abstract][Full Text] [Related]
7. Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients.
Uluc K; Isak B; Borucu D; Temucin CM; Cetinkaya Y; Koytak PK; Tanridag T; Us O
Clin Neurophysiol; 2008 Apr; 119(4):880-5. PubMed ID: 18291716
[TBL] [Abstract][Full Text] [Related]
8. Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.
Tamura N; Kuwabara S; Misawa S; Mori M; Nakata M; Hattori T
Clin Neurophysiol; 2005 Oct; 116(10):2330-3. PubMed ID: 16122982
[TBL] [Abstract][Full Text] [Related]
9. Medial dorsal superficial peroneal nerve studies in patients with polyneuropathy and normal sural responses.
Kushnir M; Klein C; Kimiagar Y; Pollak L; Rabey JM
Muscle Nerve; 2005 Mar; 31(3):386-9. PubMed ID: 15508123
[TBL] [Abstract][Full Text] [Related]
10. Simplified electrodiagnostic criteria of diabetic polyneuropathy in field study (KCIS No. 14).
Hsu WC; Chiu YH; Chen WH; Chiu HC; Liou HH; Chen TH
Neuroepidemiology; 2007; 28(1):50-5. PubMed ID: 17215587
[TBL] [Abstract][Full Text] [Related]
11. Clinical and electrophysiologic findings in dialysis patients.
Tilki HE; Akpolat T; Coşkun M; Stålberg E
J Electromyogr Kinesiol; 2009 Jun; 19(3):500-8. PubMed ID: 18155923
[TBL] [Abstract][Full Text] [Related]
12. Correlation between compound muscle action potential amplitude and duration in axonal and demyelinating polyneuropathy.
Tankisi H; Otto M; Pugdahl K; Johnsen B; Fuglsang-Frederiksen A
Clin Neurophysiol; 2012 Oct; 123(10):2099-105. PubMed ID: 22560637
[TBL] [Abstract][Full Text] [Related]
13. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy.
Dyck PJ; Lais A; Karnes JL; O'Brien P; Rizza R
Ann Neurol; 1986 May; 19(5):425-39. PubMed ID: 3717906
[TBL] [Abstract][Full Text] [Related]
14. Conduction slowing in painful versus painless diabetic neuropathy.
Seok Bae J; Sik Park S; Kim M; Joon Kim B
J Clin Neurosci; 2007 Jan; 14(1):22-6. PubMed ID: 17138066
[TBL] [Abstract][Full Text] [Related]
15. Miller Fisher syndrome: axonal, demyelinating or both?
Scelsa SN; Herskovitz S
Electromyogr Clin Neurophysiol; 2000 Dec; 40(8):497-502. PubMed ID: 11155543
[TBL] [Abstract][Full Text] [Related]
16. Strength-duration properties in diabetic polyneuropathy.
Yerdelen D; Koç F; Uysal H; Sarica Y
Diabetes Res Clin Pract; 2007 Oct; 78(1):56-9. PubMed ID: 17408800
[TBL] [Abstract][Full Text] [Related]
17. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy.
Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H
Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367
[TBL] [Abstract][Full Text] [Related]
18. Neuropathy patterns differ in patients with diabetic complications.
Kiziltan ME; Benbir G
Electromyogr Clin Neurophysiol; 2008; 48(8):351-7. PubMed ID: 19097475
[TBL] [Abstract][Full Text] [Related]
19. The effect of hyperventilation on strength-duration properties in diabetic polyneuropathy.
Yerdelen D; Uysal H; Koç F; Sarica Y
Clin Neurophysiol; 2007 Jan; 118(1):105-10. PubMed ID: 17095293
[TBL] [Abstract][Full Text] [Related]
20. Conduction velocity versus amplitude analysis: evidence for demyelination in diabetic neuropathy.
Wilson JR; Stittsworth JD; Kadir A; Fisher MA
Muscle Nerve; 1998 Sep; 21(9):1228-30. PubMed ID: 9703455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
